NEW YORK (GenomeWeb News) – Osmetech said today that it will adapt a Qiagen respiratory viral test for use on its eSensor XT-8 molecular diagnostics system.
Qiagen will supply Osmetech with its QIAplex-based reagents for the multiplex amplification of the most common viruses associated with respiratory infections. UK-based Osmetech said that it will develop an in vitro diagnostic test for use on its molecular diagnostics platform and submit the test for US Food and Drug Administration clearance.
This past summer, Qiagen launched its QIAplex-based ResPlex II respiratory panel for research use only. The panel enables detection of up to 17 different viral molecular targets, including influenza A/B and parainfluenza RSV A/B.
“This is an excellent opportunity to take an already commercially successful product into the mainstream diagnostics market,” Osmetech CEO James White said in a statement.